Why Environmentalists Should Be Concerned
By Bill McKibben,
WorldWatch
| 06. 30. 2002
July / August 2002
It's not as if environmentalists really need something new to worry about. The planet's temperature is set to rise four or five degrees-every glacial system is already in rapid retreat, and icebergs measured in units of U.S. states (the size of Rhode Island!) are calving off the Antarctic. Species disappear daily; acid rain; and you know the whole damn litany. We could be forgiven for wanting to take a pass on human genetic engineering.
And yet I think it may turn into the single greatest battle environmentalists have ever fought, the one for which the Grand Canyon and the African elephants and Amazon deforestation and Love Canal were preparing us. The real test.
Some of the reasons for thinking so are pragmatic. Changing the human germline is an almost preposterous override of the precautionary principle, the idea that if you don't know something's safe you shouldn't do it. We have rushed with blinding speed through the first phases of the biotechnological revolution-what was experimental a decade ago now grows in half the corn and soybean fields...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...